Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Chouaid

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2013
Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 studyJ Le Treut, M C Sault, H Lena, et al.
Revue Des Maladies Respiratoires|December 13, 2005
[Question 5. Strategies in respiratory therapy]F Lemoigne, J Desplans, E Lonsdorfer, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Nivolumab-refractory patients with advanced non-small-cell lung cancerA Costantini, V Fallet, J Corny, et al.
The European Respiratory Journal|June 11, 2011
Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3I Borget, J Cadranel, J-P Pignon, et al.
Revue Des Maladies Respiratoires|June 24, 2010
[Management and outcome of French elderly patients with lung cancer: an IFCT survey]E Quoix, I Monnet, P Scheid, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2023
Reduced risk of secondary primary extra pulmonary cancer in advanced/metastatic lung cancer patients treated with immune checkpoint inhibitorsP E Heudel, A de Montfort, D Debieuvre, et al.
Lung Cancer (Amsterdam, Netherlands)|August 6, 2013
What constitutes best supportive care in the treatment of advanced non-small cell lung cancer patients?--Results from the lung cancer economics and outcomes research (LUCEOR) studyJ F Lester, J Agulnik, O Akerborg, et al.
British Journal of Cancer|December 17, 2008
Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancerM J McKeage, J Von Pawel, M Reck, et al.
Revue Des Maladies Respiratoires|June 8, 2011
[Effect of tinzaparin on survival in non-small-cell lung cancer after surgery. TILT: tinzaparin in lung tumours]G Meyer, B Besse, S Friard, et al.
BMC Cancer|November 8, 2015
Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study)C Raynaud, L Greillier, J Mazieres, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2013
Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 studyJ Le Treut, M C Sault, H Lena, et al.
Revue Des Maladies Respiratoires|December 13, 2005
[Question 5. Strategies in respiratory therapy]F Lemoigne, J Desplans, E Lonsdorfer, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Nivolumab-refractory patients with advanced non-small-cell lung cancerA Costantini, V Fallet, J Corny, et al.
The European Respiratory Journal|June 11, 2011
Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3I Borget, J Cadranel, J-P Pignon, et al.
Revue Des Maladies Respiratoires|June 24, 2010
[Management and outcome of French elderly patients with lung cancer: an IFCT survey]E Quoix, I Monnet, P Scheid, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2023
Reduced risk of secondary primary extra pulmonary cancer in advanced/metastatic lung cancer patients treated with immune checkpoint inhibitorsP E Heudel, A de Montfort, D Debieuvre, et al.
Lung Cancer (Amsterdam, Netherlands)|August 6, 2013
What constitutes best supportive care in the treatment of advanced non-small cell lung cancer patients?--Results from the lung cancer economics and outcomes research (LUCEOR) studyJ F Lester, J Agulnik, O Akerborg, et al.
British Journal of Cancer|December 17, 2008
Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancerM J McKeage, J Von Pawel, M Reck, et al.
Revue Des Maladies Respiratoires|June 8, 2011
[Effect of tinzaparin on survival in non-small-cell lung cancer after surgery. TILT: tinzaparin in lung tumours]G Meyer, B Besse, S Friard, et al.
BMC Cancer|November 8, 2015
Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study)C Raynaud, L Greillier, J Mazieres, et al.
Pageof 12